臨床試驗

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

NCT：NCT04502316 · TERMINATED

NCT IDNCT04502316

狀態TERMINATED

開始日期2020-06-26

完成時間2026-06-30

SponsorCVRx, Inc. (INDUSTRY)

First posted2020-08-06

Last updated2026-09-17

簡要摘要

The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。